Pharmaceutical Industry news

• More Than One in Four Adults Eligible for GLP-1 Receptor Agonists

  14-01-2026 17:45 via drugs.com
  WEDNESDAY, Jan. 14, 2026-- More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a glucagon-like peptide-1 (GLP-1) receptor agonist, according to a research letter published in the February issue of The...
  
  Read more

• Evidence Insufficient to Support Routine Lumbar Support Use for Chronic Low Back Pain

  04-09-2026 21:32 via drugs.com
  FRIDAY, Sept. 4, 2026-- The evidence is insufficient to support routine use of lumbar supports for managing chronic low back pain (CLBP) in adults, according to research published online Sept. 2 in the Cochrane Database of Systematic...
  
  Read more

• People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users

  04-09-2026 21:24 via drugs.com
  FRIDAY, Sept. 4, 2026-- Illicit-source fentanyl exposure is linked to a significantly higher risk of opioid-related harmful outcomes than medical-source exposure, according to a study published online Aug. 14 in eClinicalMedicine.Seungyeon Lee...
  
  Read more

• Recommendations Updated for Adult Stroke Rehabilitation, Recovery

  04-09-2026 16:22 via drugs.com
  FRIDAY, Sept. 4, 2026-- Updated recommendations are presented for adult stroke rehabilitation and recovery in a guideline issued by the American Heart Association and American Stroke Association and published online Aug. 27 in Stroke.Lorie G...
  
  Read more

• Advertisement

• NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease

  04-09-2026 16:18 via drugs.com
  FRIDAY, Sept. 4, 2026-- For patients with atrial fibrillation (AF) and Alzheimer disease (AD), non-vitamin K oral anticoagulants (NOACs) are associated with modestly slower cognitive decline, according to a study published online Aug. 12 in the...
  
  Read more

• Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer

  04-09-2026 16:12 via drugs.com
  FRIDAY, Sept. 4, 2026-- For patients with prostate cancer, adverse pathological features are prognostic, but do not modify the benefit of adding hormone therapy (HT) to postoperative radiotherapy, according to a study published online July 28 in...
  
  Read more

• Preoperative IV Iron Beneficial for Patients With Anemia Undergoing Cardiac Surgery

  04-09-2026 16:07 via drugs.com
  FRIDAY, Sept. 4, 2026-- For patients with anemia undergoing elective cardiac surgery, preoperative intravenous iron is associated with improved outcomes, according to a study published online Aug. 19 in The BMJ.Paul S. Myles, M.B.B.S., M.P.H...
  
  Read more

• Dementia, Stroke Risk Elevated for Those With Severe Mental Illness

  04-09-2026 16:03 via drugs.com
  FRIDAY, Sept. 4, 2026-- Individuals with severe mental illness (SMI) have increased odds ratios for dementia and ischemic stroke, even at younger ages, according to a study published in the September issue of European...
  
  Read more

• Advertisement

• Alcohol-Attributable Cancer Mortality Has Increased Significantly in the U.S.

  03-09-2026 23:00 via drugs.com
  THURSDAY, Sept. 3, 2026-- Alcohol-attributable cancer mortality has increased in the United States, with mortality rates higher in men and those aged 55 years or older, according to a study published online Sept. 2 in The Lancet Regional Health...
  
  Read more

• FDA Approves First-in-Class Drug for Polycythemia Vera

  03-09-2026 22:56 via drugs.com
  THURSDAY, Sept. 3, 2026-- The U.S. Food and Drug Administration has approved Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.Mimrylo mimics hepcidin, a...
  
  Read more

• FDA Approves Mimrylo, a First-in-Class Drug for Polycythemia Vera

  03-09-2026 22:09 via drugs.com
  THURSDAY, Sept. 3, 2026 -- The U.S. Food and Drug Administration has approved Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.
  Mimrylo mimics hepcidin, a...
  
  Read more

• Maintaining Physical Activity Tied to Better Quality of Life With Multiple Sclerosis

  03-09-2026 17:35 via drugs.com
  THURSDAY, Sept. 3, 2026-- Functional physical performance is positively associated with quality of life (QoL) in people with relapsing-remitting multiple sclerosis (RRMS), according to a study published online Aug. 23 in Multiple Sclerosis and...
  
  Read more

• Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML

  03-09-2026 17:35 via drugs.com
  THURSDAY, Sept. 3, 2026-- For adults with acute myeloid leukemia (AML) eligible for induction chemotherapy, azacitidine plus venetoclax is associated with longer event-free survival than induction chemotherapy, according to a study published in...
  
  Read more

• Very Low-Carb Diet Shows Greater Cardiometabolic Benefits Than Other Diets

  03-09-2026 17:32 via drugs.com
  THURSDAY, Sept. 3, 2026-- A very low-carbohydrate diet has greater cardiometabolic benefits, particularly in hepatic metabolic function, compared with matched 10 percent weight loss induced by other popular diets in people with metabolically...
  
  Read more

• About 1 in 20 Hospitalized U.S. Adults With Firearm Injuries Develop Bacterial Infections

  03-09-2026 17:28 via drugs.com
  THURSDAY, Sept. 3, 2026-- Bacterial infection during initial hospitalization for firearm injury occurred in about 5 percent of patients, according to a study published online Aug. 3 in JAMA Network Open.Jerry Yang, from the University of Maryland...
  
  Read more

• Intensive BP Lowering Reduces Recurrent Stroke After Intracerebral Hemorrhage

  03-09-2026 17:23 via drugs.com
  THURSDAY, Sept. 3, 2026-- Intensive blood pressure-lowering treatment after intracerebral hemorrhage reduces the risk for recurrent stroke without an increase in serious adverse events, according to a study published in the September issue of The...
  
  Read more

• Focal Therapy Use Remains Uncommon in Nonmetastatic Prostate Cancer

  03-09-2026 16:57 via drugs.com
  THURSDAY, Sept. 3, 2026-- For patients with nonmetastatic prostate cancer, focal therapy use has remained uncommon across risk groups, and its use is defined as inappropriate in about half of recipients, according to a research letter published...
  
  Read more

• Causes, Outcomes of Traumatic Brain Injury Identified Worldwide

  03-09-2026 16:50 via drugs.com
  THURSDAY, Sept. 3, 2026-- Causes of traumatic brain injury (TBI) and outcomes vary worldwide, according to a study published online Aug. 19 in Nature Medicine.Joseph G. Nugent, M.D., M.P.H., from the Oregon Health & Science University in...
  
  Read more

• FDA Clears Blood Test for Alzheimer Disease

  03-09-2026 16:44 via drugs.com
  THURSDAY, Sept. 3, 2026-- The U.S. Food and Drug Administration has cleared the PrecivityAD2 test for adults aged 40 years and older presenting with signs or symptoms of cognitive impairment and undergoing evaluation for Alzheimer disease or other...
  
  Read more

• Time-Restricted Eating May Help Patients With Type 1 Diabetes

  02-09-2026 22:26 via drugs.com
  WEDNESDAY, Sept. 2, 2026-- Time-restricted eating (TRE) may help adults with type 1 diabetes (T1D) and overweight control their blood sugar, according to a study published online Aug. 17 in Diabetes Care.Mary-Claire Runchey, R.D., from the...
  
  Read more

• Residential Context Has Larger Impact on Ovarian Cancer Survival in Black Women

  02-09-2026 22:23 via drugs.com
  WEDNESDAY, Sept. 2, 2026-- Residential context has a stronger association with survival for Black than White women with epithelial ovarian cancer (EOC), according to a study published online Aug. 10 in JAMA Network Open.Francesmary Modugno, Ph.D...
  
  Read more

• ESC: Silent Atherosclerosis Present in 57.1 Percent of Adults Aged 18 to 70

  02-09-2026 17:45 via drugs.com
  WEDNESDAY, Sept. 2, 2026-- Silent atherosclerosis is detectable in early adulthood and increases with age, according to a study published online Aug. 29 in the New England Journal of Medicine to coincide with the annual meeting of the European...
  
  Read more

• ESC: Atorvastatin Lowers Cardiovascular Event Risk in Older Adults Without Clinical CVD

  02-09-2026 17:41 via drugs.com
  WEDNESDAY, Sept. 2, 2026-- For community-dwelling older adults without clinical cardiovascular disease, atorvastatin is associated with a lower risk for major cardiovascular events, but does not improve disability-free survival, according to a...
  
  Read more

• Updated Recommendations Address Medications to Prevent Migraine in Adults

  02-09-2026 17:38 via drugs.com
  WEDNESDAY, Sept. 2, 2026-- Updated recommendations are presented to help clinicians decide which medications may be effective for preventing migraine in adults in two reports issued by the American Academy of Neurology and American Headache...
  
  Read more

• Recommendations Updated for Radiation Therapy in Pancreatic Cancer

  02-09-2026 17:34 via drugs.com
  WEDNESDAY, Sept. 2, 2026-- Updated recommendations are presented for the use of radiation therapy (RT) in pancreatic cancer in a clinical practice guideline issued by the American Society for Radiation Oncology and published online Aug. 11 in...
  
  Read more

• Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy

  02-09-2026 17:31 via drugs.com
  WEDNESDAY, Sept. 2, 2026-- For women with autoimmune disease who had received autologous CD19-chimeric antigen receptor (CAR) T-cell therapy, pregnancies seem to be uncomplicated without disease reactivation, according to a study published in the...
  
  Read more

• CDC: Buprenorphine Treatment Differs in Urban, Rural Areas

  02-09-2026 00:56 via drugs.com
  TUESDAY, Sept. 1, 2026-- Buprenorphine access and treatment differ between urban and rural areas, according to research published in the Aug. 27 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly...
  
  Read more

• Cancer Risk ID'd for Asian American, NHPI Population

  02-09-2026 00:54 via drugs.com
  TUESDAY, Sept. 1, 2026-- Considerable differences are seen in the incidence of cancers among Asian American and Native Hawaiian and Pacific Islander (NHPI) people, according to a study published online Aug. 27 in Cancer.Nikita Sandeep Wagle...
  
  Read more

• FDA Approves Lisraya for Dermatomyositis in Adults

  01-09-2026 17:04 via drugs.com
  TUESDAY, Sept. 1, 2026-- The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets as the first oral treatment of dermatomyositis in adults.The approval was based on results from a phase 3 trial in which 241 adults with...
  
  Read more

• Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects

  01-09-2026 17:03 via drugs.com
  TUESDAY, Sept. 1, 2026-- Lower predicted prevalences of birth defects are seen in association with periconception parental vitamin B12 and postconception maternal red blood cell (RBC) folate, according to a study published online Sept. 1 in the...
  
  Read more

Follow @PharmaIndustry_ on Twitter!